» Authors » Yesim Parman

Yesim Parman

Explore the profile of Yesim Parman including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 86
Citations 3637
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Bertini A, Reilly M, Pisciotta C, Previtali S, Parman Y, Battaloglu E, et al.
Eur J Neurol . 2025 Feb; 32(2):e70084. PMID: 39943887
Background And Aims: In 2019, we conducted a cross-sectional study, collecting information on 50 patients with CMT4B, an ultrarare CMT subtype, to better define the clinical phenotype. We now aimed...
2.
Cortese A, Dohrn M, Curro R, Negri S, Lassuthova P, Pisciotta C, et al.
Brain . 2025 Feb; PMID: 39938083
Biallelic loss-of-function mutations in the sorbitol dehydrogenase (SORD) gene cause the most common recessive type of Charcot-Marie-Tooth disease (CMT), CMT-SORD. However, the full genotype-phenotype spectrum and progression of the disease...
3.
Cakar A, Candayan A, Bagirova G, Uyguner Z, Ceylaner S, Durmus H, et al.
Eur J Neurol . 2025 Jan; 32(1):e16572. PMID: 39776111
Background: Charcot-Marie-Tooth (CMT) disease is the most common inherited neuropathy. In this study, we aimed to analyze the genetic spectrum and describe phenotypic features in a large cohort from Türkiye....
4.
Cebi M, Cakar A, Durmus H, Akan O, Aysal F, Parman Y, et al.
Eur J Immunol . 2024 Sep; 54(11):e2451268. PMID: 39285833
Follicular helper (Tfh), peripheral helper (Tph), and regulatory (Treg) T cells are involved in myasthenia gravis (MG) pathogenesis, an autoimmune disorder arising from autoantibodies targeting neuromuscular junction proteins. This study...
5.
Altinonder I, Kaya M, Yentur S, Cakar A, Durmus H, Yegen G, et al.
J Neuroinflammation . 2024 May; 21(1):126. PMID: 38734662
Myasthenia gravis (MG) is an immune-mediated disease frequently associated with thymic changes. Increased T helper 17 (Th17) cell activity and dysfunctional regulatory T (Treg) cells have been demonstrated in subgroups...
6.
Tasdemir V, Sirin N, Cakar A, Culha A, Soysal A, Elmali A, et al.
J Peripher Nerv Syst . 2024 Jan; 29(1):72-81. PMID: 38291679
Background And Aims: This study aimed to identify the clinical characteristics and electrodiagnostic subtypes of Guillain-Barré syndrome (GBS) in Istanbul. Methods: Patients with GBS were prospectively recruited between April 2019...
7.
Cakar A, Maroofian R, Parman Y, Reilly M, Houlden H
Brain Commun . 2024 Jan; 6(1):fcae003. PMID: 38274568
No abstract available.
8.
Lischka A, Eggermann K, Record C, Dohrn M, Lassuthova P, Kraft F, et al.
Brain . 2023 Sep; 146(12):4880-4890. PMID: 37769650
Congenital insensitivity to pain (CIP) and hereditary sensory and autonomic neuropathies (HSAN) are clinically and genetically heterogeneous disorders exclusively or predominantly affecting the sensory and autonomic neurons. Due to the...
9.
Coelho T, Marques Jr W, Dasgupta N, Chao C, Parman Y, Franca Jr M, et al.
JAMA . 2023 Sep; 330(15):1448-1458. PMID: 37768671
Importance: Transthyretin gene silencing is an emerging treatment strategy for hereditary transthyretin (ATTRv) amyloidosis. Objective: To evaluate eplontersen, an investigational ligand-conjugated antisense oligonucleotide, in ATTRv polyneuropathy. Design, Setting, And Participants:...
10.
Ozdag Acarli A, Tuzun E, Sanli E, Koral G, Akbayir E, Cakar A, et al.
Clin Exp Immunol . 2023 Aug; 215(1):65-78. PMID: 37638717
Chronic inflammatory demyelinating polyneuropathy (CIDP), a common and treatable autoimmune neuropathy, is frequently misdiagnosed. The aim of this study is to evaluate the relationship between immunological markers and clinical outcome...